Risks and benefits of a multidrug approach to mild-to-moderate heart failure

American Journal of Medicine

Volumn 110, Issue 7, 2001, Pages 63-67

  Piña, Ileana L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; METOPROLOL; PRAZOSIN; VASODILATOR AGENT;

BRADYCARDIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COUGHING; DIGITALIS INTOXICATION; DRUG MONITORING; FLUID RETENTION; HEART FAILURE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; NEPHROTOXICITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT;

EID: 0035821232     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00554-4     Document Type: Review

References (10)

1. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study
2. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
4. The effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
5. The cardiac insufficiency bisoprolol study II (CIBIS II): A randomized trial
6. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors
7. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
8. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial